Background: Phosphaturic mesenchymal tumours (PMTs) are rare neoplasms causing oncogenic osteomalacia. They are typically benign; malignant transformation is uncommon with limited clinical evidence on long term management. 1
Hu et al. (Sun,) studied this question.